Moreover, in TNF-α activated monocytes, ITF3756 reduces the expression of additional biomarkers of severe COVID-19, such as PTX3, ICAM-1, S100A12, PD-L1 and MMP9, further supporting a potential role for this molecule in the treatment of the disease. The gene discussed is ICAM1; the disease is COVID-19.